EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Exome Sequencing in Unexplained Hyperferritinemia Reveals Digenic and Oligogenic Inheritance Beyond Iron Homeostasis

Paul Morel, Maël Silva Rodriguez iD, Cyriaque Benmouffek, Betul Goksen, Céline Chéry, Vincent Haghnejad iD, Mouni Bensenane, François Feillet iD, Jean-Louis Guéant, Farès Namour, Jean-Pierre Bronowicki iD, Abderrahim Oussalah iD

Liver International · 2026

DOI: 10.1111/liv.70646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Paul Morel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, Division of Biochemistry, Molecular Biology, and Nutrition, University Hospital of Nancy, Nancy, France. Hauptthemen laut MEDLINE: Hemochromatosis Protein, Hyperferritinemia, Iron. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hyperferritinemia encompasses heterogeneous genetic etiologies beyond HFE ‐related hemochromatosis. Current guidelines recommend testing for rare hemochromatosis genes, yet no consensus exists on comprehensive genomic approaches. We aimed to characterise the genetic landscape of unexplained hyperferritinemia using clinical exome sequencing (CES) and evaluate genotype–phenotype correlations across functional pathways.

Methods

In this retrospective study (2019–2024), consecutive patients with unexplained hyperferritinemia after exclusion of secondary causes underwent CES. Patients with known HFE p.Cys282Tyr homozygosity were not referred for CES. Variant filtering was performed using the Genomics England panel for iron metabolism and the French network for rare liver diseases panel, combined with phenotype‐driven analysis based on Human Phenotype Ontology annotations for iron‐related phenotypes. Genes were categorised into four pathways: systemic iron sensing, iron transport and storage, hepatic metabolism and erythropoiesis.

Results

Among 108 patients, CES identified at least one variant in 72 (66.7%), including 44 (40.7%) with likely pathogenic or pathogenic (LP/P) variants. HFE was the most frequently affected gene, followed by SERPINA1 , ATP7B , and CP . Among patients without monogenic HFE alterations ( n = 57), 21 (36.8%) carried variants, mainly affecting CP , ATP7B , SERPINA1 or GBA . Digenic or oligogenic inheritance was observed in 30.6% (22/72) of patients overall and in 20.5% (9/44) of those carrying LP/P variants, most frequently involving HFE ‐ SERPINA1 and HFE ‐ ATP7B combinations. Cross‐pathway combinations occurred in 17 of 22 digenic patients (77.3%). The systemic iron sensing group exhibited significantly higher serum iron ( p = 0.009) and transferrin saturation ( p = 0.008).

Conclusions

CES reveals genetic heterogeneity beyond the traditional Mendelian framework, with frequent non‐ HFE gene involvement and digenic inheritance and should be considered after exclusion of HFE p.Cys282Tyr homozygosity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemochromatosis ProteinHyperferritinemiaIronHumansExome SequencingFemaleMaleRetrospective StudiesMiddle AgedHomeostasisAdultGenetic Association StudiesPhenotypeHemochromatosis

Stichwörter der Autor:innen

clinical exome sequencingdigenic inheritancegenotype–phenotype correlationhemochromatosishyperferritinemiairon overload

Substanzen

Hemochromatosis ProteinIronHFE protein, human

Autor:innen und Institutionen

  • Department of Genomic Medicine, Division of Biochemistry, Molecular Biology, and Nutrition, University Hospital of Nancy, Nancy, France.
  • Reference Center for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy, France.
  • Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.
  • INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Nancy, France.
  • Department of Gastroenterology and Liver Diseases, University Hospital of Nancy, Nancy, France.
  • Department of Paediatrics, University Hospital of Nancy, Nancy, France.

ORCID-Profile: Maël Silva Rodriguez, Vincent Haghnejad, François Feillet, Jean-Pierre Bronowicki, Abderrahim Oussalah

Zitieren

APA

Morel, P., Silva Rodriguez, M., Benmouffek, C., Goksen, B., Chéry, C., Haghnejad, V., Bensenane, M., Feillet, F., Guéant, J. L., Namour, F., Bronowicki, J. P., & Oussalah, A. (2026). Clinical Exome Sequencing in Unexplained Hyperferritinemia Reveals Digenic and Oligogenic Inheritance Beyond Iron Homeostasis. Liver International. https://doi.org/10.1111/liv.70646

Vancouver

Morel P, Silva Rodriguez M, Benmouffek C, Goksen B, Chéry C, Haghnejad V, et al. Clinical Exome Sequencing in Unexplained Hyperferritinemia Reveals Digenic and Oligogenic Inheritance Beyond Iron Homeostasis. Liver International. 2026. doi:10.1111/liv.70646

BibTeX
@article{Morel2026,
  author = {Morel, Paul and Silva Rodriguez, Maël and Benmouffek, Cyriaque and Goksen, Betul and Chéry, Céline and Haghnejad, Vincent and Bensenane, Mouni and Feillet, François and Guéant, Jean-Louis and Namour, Farès and Bronowicki, Jean-Pierre and Oussalah, Abderrahim},
  title = {Clinical Exome Sequencing in Unexplained Hyperferritinemia Reveals Digenic and Oligogenic Inheritance Beyond Iron Homeostasis},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70646}
}
Kostenlos starten →